betamethasone dipropionate
- RxCUI
- 19254
- RxNorm name
- betamethasone dipropionate
- Term type
- PIN
- Status
- Active
- Updated
- 2026-10-27 19:32:40
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| betamethasone | 1514 |
Source Vocabulary Codes#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | REMEDYREPACK INC. | 7cacf0ec-3db9-48be-9a76-93ed4a1f042c | 2026-08-31 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 97dde5f5-a865-4af2-b562-8da72c8475f3 | 2026-08-21 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 0173ed23-9f7c-466e-9eba-f6859d05f987 | 2026-07-29 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Redpharm Drug | 5718b3bd-77b3-8034-e063-6294a90af5e0 | 2026-07-21 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | b5291e39-40a0-4362-9281-97f5fb4025d9 | 2026-05-11 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Aurobindo Pharma Limited | a4f8db3a-0aed-451c-98ba-c4ce37656792 | 2026-05-04 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Sernivo | BETAMETHASONE DIPROPIONATE | Primus Pharmaceuticals, Inc. | b1b3d1b0-da9b-11eb-ad76-0800200c9a66 | 2026-04-22 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Preferred Pharmaceuticals, Inc. | 5683885d-461c-4e7e-bbe8-dc231d706192 | 2026-03-19 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Preferred Pharmaceuticals, Inc. | 54eff1fc-c611-4929-bb44-c1834c08f506 | 2026-03-19 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | abd5a08c-4bb7-46c9-9e2e-0a89c43d46c8 | 2026-02-06 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 4f411e41-00dc-47cf-8517-3ff5876e1bf5 | 2026-01-30 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 853399f8-95a7-41f3-80e7-7ed8e3ff1a5e | 2026-01-30 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Prasco Laboratories | f5b50c00-cc6f-4296-a9ae-b16888cef4dd | 2025-11-19 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| DIPROLENE | BETAMETHASONE DIPROPIONATE | Organon LLC | 0b9543ad-2ca7-430d-aef9-81c376dc2e6c | 2025-11-19 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Lupin Pharmaceuticals, Inc. | 216d5b7f-4236-4882-b899-be17cb1a1584 | 2025-11-13 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Encube Ethicals, Inc. | 7e946599-2fb4-4426-bb59-fbb71d89dac8 | 2025-11-11 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Bryant Ranch Prepack | 1d40b962-5d97-4416-b46d-b0785acd261d | 2025-10-21 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Sun Pharmaceutical Industries, Inc. | 000ae256-a337-4903-845b-003777a4efa8 | 2025-09-26 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Bryant Ranch Prepack | 13196f0a-6daf-4f62-853c-ac2ac261ce43 | 2025-09-12 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Bryant Ranch Prepack | f2c557ea-275b-4ab4-90f4-4003e022214d | 2025-08-07 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C05AA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | S03BA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | S02BA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | R01AD | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | betamethasone | |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | betamethasone | |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | betamethasone | |
| ATC | D07XC | Corticosteroids, potent, other combinations | ATC1-4 | betamethasone | |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | betamethasone | |
| ATC | R03BA | Glucocorticoids | ATC1-4 | betamethasone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | betamethasone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | betamethasone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone dipropionate |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone dipropionate |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone dipropionate |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone dipropionate |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone dipropionate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone dipropionate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | SNOMEDCT | 88736007 |
| CODES | USP | m8960 |
| CODES | VUID | 4018642 |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |